Swiss Nanoanalytics

The Swiss NanoAnalytics platform within the Adolphe Merkle Institute's BioNanomaterials group offers high quality services for the analysis of nanoparticles. This includes characterization of the physicochemical properties of nanomaterials, isolation and analysis of the occurrence of particles in food products and cosmetics, testing the stability and size of nanomedicines in biological fluids (e.g. blood serum), and testing material composites used in electronics or construction materials. Furthermore, in connection with the development of Covid-19 vaccines or therapeutic nanocarriers (e.g. liposomal or polymer capsules), we offer characterization services, support the characterization of such vaccines or nanocarriers and provide relevant information at an early stage of development. We offer a number of services related to the detection and analysis of nanoparticles- Characterization of raw materials like powders and nanoparticles (Particle size, shape or elemental composition )- Detection of particles in consumer products such as cosmetics or food (Particle presence, size and elemental composition)- Characterization of nanomedicines (vesicles, liposomes, polymer particles, mRNA vaccines, biomedical products, drug carriers). Particle size and colloidal stability can be analyzed in specific suspensions (physiological suspensions, plasma, cell culture medium)- Filter efficiency measurements or on other virucidal systems (with MS2 bacteriophages) We also offer development of procedures, consulting, training workshops (e.g. light scattering, electron microscopy, cell culture).